Goldman Sachs adjusts Evotec stake
Analysis based on 41 articles · First reported Apr 02, 2026 · Last updated Jun 01, 2026
The market impact is likely minimal as the change in voting rights by Goldman Sachs>>> in Evotec>>> is a routine regulatory disclosure and does not indicate a significant shift in control or a major strategic move. Investors may note the slight reduction in Goldman Sachs>>>'s overall stake, but it is unlikely to cause substantial stock price fluctuations for Evotec>>>.
This event concerns multiple voting rights announcements by Evotec>>> SE, a publicly traded company, in accordance with Article 40, Section 1 of the German Securities Trading Act (WpHG). The key development is a notification from Goldman Sachs>>> regarding a change in its total voting rights in Evotec>>>. As of April 21, 2026, Goldman Sachs>>>'s total voting rights in Evotec>>> decreased from 7.30% to 6.66%. This change was triggered by an acquisition/disposal of shares with voting rights and other reasons, specifically a voluntary group notification with a triggered threshold at the subsidiary level. The announcement details the breakdown of voting rights attached to shares and various instruments, including rights to recall, rights of use, swaps, and call warrants.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard